These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15159316)

  • 1. Myeloperoxidase (MPO) -463G->A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers.
    Van Schooten FJ; Boots AW; Knaapen AM; Godschalk RW; Maas LM; Borm PJ; Drent M; Jacobs JA
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):828-33. PubMed ID: 15159316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase--463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients.
    Rojas M; Godschalk R; Alexandrov K; Cascorbi I; Kriek E; Ostertag J; Van Schooten FJ; Bartsch H
    Carcinogenesis; 2001 Jul; 22(7):1015-8. PubMed ID: 11408343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.
    Lodovici M; Luceri C; Guglielmi F; Bacci C; Akpan V; Fonnesu ML; Boddi V; Dolara P
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1342-8. PubMed ID: 15298956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
    Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population.
    Park JH; Park JM; Kim EJ; Cha SI; Lee EB; Kim CH; Kam S; Jung TH; Park JY
    Cancer Detect Prev; 2006; 30(3):257-61. PubMed ID: 16844322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant--463A of the myeloperoxidase gene.
    Cascorbi I; Henning S; Brockmöller J; Gephart J; Meisel C; Müller JM; Loddenkemper R; Roots I
    Cancer Res; 2000 Feb; 60(3):644-9. PubMed ID: 10676648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation of myeloperoxidase gene contributes to atopic asthma susceptibility: a preliminary association study in Russian population.
    Polonikov AV; Solodilova MA; Ivanov VP
    J Asthma; 2009 Jun; 46(5):523-8. PubMed ID: 19544176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
    Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
    Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure.
    Dallinga JW; Pachen DM; Wijnhoven SW; Breedijk A; van 't Veer L; Wigbout G; van Zandwijk N; Maas LM; van Agen E; Kleinjans JC; van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):571-7. PubMed ID: 9681524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index modulates aromatic DNA adduct levels and their persistence in smokers.
    Godschalk RW; Feldker DE; Borm PJ; Wouters EF; van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):790-3. PubMed ID: 12163336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes.
    Mäkelä R; Loimaala A; Nenonen A; Mercuri M; Vuori I; Huhtala H; Oja P; Bond G; Koivula T; Lehtimäki T
    Clin Biochem; 2008 May; 41(7-8):532-7. PubMed ID: 18280811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients.
    Ryberg D; Hewer A; Phillips DH; Haugen A
    Cancer Res; 1994 Nov; 54(22):5801-3. PubMed ID: 7954403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts in lung, lower esophagus and cardia of sudden death victims.
    Schlöbe D; Hölzle D; Hatz D; von Meyer L; Tricker AR; Richter E
    Toxicology; 2008 Mar; 245(1-2):154-61. PubMed ID: 18243467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer.
    Zhu J; Chang P; Bondy ML; Sahin AA; Singletary SE; Takahashi S; Shirai T; Li D
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):830-7. PubMed ID: 14504191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase G-463A polymorphism and risk of lung and prostate cancer in a Turkish population.
    Arslan S; Pinarbasi H; Silig Y
    Mol Med Rep; 2011; 4(1):87-92. PubMed ID: 21461569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers.
    Van Schooten FJ; Besaratinia A; De Flora S; D'Agostini F; Izzotti A; Camoirano A; Balm AJ; Dallinga JW; Bast A; Haenen GR; Van't Veer L; Baas P; Sakai H; Van Zandwijk N
    Cancer Epidemiol Biomarkers Prev; 2002 Feb; 11(2):167-75. PubMed ID: 11867504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study.
    Zhu H; Yang L; Zhou B; Yu R; Tang N; Wang B
    Carcinogenesis; 2006 Dec; 27(12):2491-6. PubMed ID: 16829688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of DNA adduct levels in nasal mucosa, lymphocytes and bronchial mucosa of cigarette smokers and interaction with metabolic gene polymorphisms.
    Peluso M; Neri M; Margarino G; Mereu C; Munnia A; Ceppi M; Buratti M; Felletti R; Stea F; Quaglia R; Puntoni R; Taioli E; Garte S; Bonassi S
    Carcinogenesis; 2004 Dec; 25(12):2459-65. PubMed ID: 15319297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchial malondialdehyde DNA adducts, tobacco smoking, and lung cancer.
    Munnia A; Bonassi S; Verna A; Quaglia R; Pelucco D; Ceppi M; Neri M; Buratti M; Taioli E; Garte S; Peluso M
    Free Radic Biol Med; 2006 Nov; 41(9):1499-505. PubMed ID: 17023277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.